Genmab
GMAB
17,76 €
Share price
-0.69%
Change (1 day)
-33.42%
Change (1 year)
Categories
Earnings for Genmab (GMAB)
Earnings in 2024 (TTM): €1.22 Billion
According to Genmab's latest financial reports the company's current earnings are €3.10 Billion. , an increase over its 2023 earnings that were of €0.70 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Genmab from 2009 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | €1.16 B | 63.99% |
| 2023 | €0.70 B | -17.29% |
| 2022 | €0.85 B | 55.87% |
| 2021 | €0.54 B | -31.09% |
| 2020 | €0.79 B | 111.51% |
| 2019 | €0.37 B | 69.44% |
| 2018 | €0.22 B | 49.63% |
| 2017 | €0.14 B | 3.27% |
| 2016 | €0.14 B | 46.33% |
| 2015 | €98.26 M | 117.13% |
| 2014 | €45.25 M | 329.17% |
| 2013 | €10.54 M | -159.26% |
| 2012 | -€17.8 Million | -48.96% |
| 2011 | -€34.87 Million | 90.86% |
| 2010 | -€18.27 Million | -67.46% |
| 2009 | -€56.15 Million |